Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...

BERLIN, Oct. 15, 2024 /PRNewswire/ -- Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to ...

Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma ...

Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...

The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs against six parasitic ...

Boehringer Ingelheim’s Bultavo 3 is among the first vaccines delivered, along with Virbac’s Syvazul BTV3, while Ceva Animal Health’s Bluevac-3 will be available in the UK from mid-October.

Earlier this month, Boehringer Ingelheim, a leader in animal health, said it is stepping up its efforts to combat rabies in the country. It said that in response to the worst outbreak of rabies in ...

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking ... along with the integration of a new animal health business bought from Sanofi ...

Zoetis excels in innovation, creating new categories and consistently raising the standard of care, outperforming competitors ...

Daily headlines, straight to your inboxRead it online first and stay up-to-date, delivered daily at 7 AM Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health.